Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/05 → 12/31/07 |
A Double-Blind, Multi-Center, Active-Controlled (15, 30, and 45mg Pioglitazone) Long Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar (0.5 and 1mg) in Patients with Type 2 Diabetes Melitus (Gallex 6)
- Reynolds, L (PI)
- Anderson, James (CoI)
- Karounos, Dennis (CoI)